TradingKey

關於 Glaukos Corp 公司

Glaukos Corporation 是一家眼科藥物和醫療技術公司。該公司開發新型無滴療法，並將相關產品商業化，用於治療青光眼、角膜疾病和視網膜疾病。其候選產品包括微創青光眼手術產品，該產品涉及插入微型裝置，旨在通過恢復青光眼患者的自然房水流出途徑來降低眼壓 (IOP)，以及基於前房內藥物輸送技術的程序性藥物，旨在通過長時間從眼內輸送治療水平的青光眼藥物來降低眼壓。其產品包括應用於眼瞼的透皮藥物，旨在治療青光眼、乾眼症、老花眼和其他眼表疾病和障礙，以及微創、生物可侵蝕的緩釋藥物輸送植入物，以改善患者的視力。

公司簡介

公司代碼GKOS

公司名稱Glaukos Corp

上市日期Jun 25, 2015

CEOMr. Thomas William Burns

員工數量995

證券類型Ordinary Share

年結日Jun 25

公司地址1 Glaukos Way

城市ALISO VIEJO

上市交易所NYSE Consolidated

國家United States of America

郵編92656

電話19493679600

網址https://www.glaukos.com

公司代碼GKOS

上市日期Jun 25, 2015

CEOMr. Thomas William Burns

公司高階主管

名稱

名稱/職務

職務

持股

持股變動

Mr. Thomas William Burns

Chairman of the Board, Chief Executive Officer

1.50M

-0.34%

Mr. David F. Hoffmeister

Independent Director

69.52K

+56.16%

Mr. Mark J. Foley

Lead Independent Director

56.36K

+3.89%

Ms. Aimee S. Weisner, J.D.

Independent Director

49.23K

+4.47%

Dr. Tomas Navratil

Chief Development Officer

38.02K

-2.55%

Mr. Marc A. Stapley

Independent Director

36.18K

+6.19%

Dr. Leana S. Wen, M.D.

Independent Director

--

Dr. Gilbert H. (Gil) Kliman, M.D.

Independent Director

--

Ms. Denice M. Torres, J.D.

Independent Director

--

Mr. Joseph E. Gilliam

President, Chief Operating Officer

--

名稱

名稱/職務

職務

持股

持股變動

Mr. Thomas William Burns

Chairman of the Board, Chief Executive Officer

1.50M

-0.34%

Mr. David F. Hoffmeister

Independent Director

69.52K

+56.16%

Mr. Mark J. Foley

Lead Independent Director

56.36K

+3.89%

Ms. Aimee S. Weisner, J.D.

Independent Director

49.23K

+4.47%

Dr. Tomas Navratil

Chief Development Officer

38.02K

-2.55%

Mr. Marc A. Stapley

Independent Director

36.18K

+6.19%

收入明細

單位: USD更新時間: 7月6日週日

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

業務USD

名稱

營收

佔比

Glaucoma

88.14M

82.63%

Corneal Health

18.53M

17.37%

地區USD

名稱

營收

佔比

United States

75.07M

70.38%

International

31.59M

29.62%

業務

地區

業務USD

名稱

營收

佔比

Glaucoma

88.14M

82.63%

Corneal Health

18.53M

17.37%

股東統計

更新時間: 8月3日週日

持股股東

股東類型

持股股東

佔比

BlackRock Institutional Trust Company, N.A.

13.35%

The Vanguard Group, Inc.

10.40%

Fidelity Management & Research Company LLC

9.73%

Wellington Management Company, LLP

4.00%

State Street Global Advisors (US)

3.47%

Other

59.06%

持股股東

佔比

BlackRock Institutional Trust Company, N.A.

13.35%

The Vanguard Group, Inc.

10.40%

Fidelity Management & Research Company LLC

9.73%

Wellington Management Company, LLP

4.00%

State Street Global Advisors (US)

3.47%

Other

59.06%

股東類型

持股股東

佔比

Investment Advisor

53.97%

Investment Advisor/Hedge Fund

34.40%

Hedge Fund

8.12%

Individual Investor

3.33%

Research Firm

1.86%

Pension Fund

1.85%

Sovereign Wealth Fund

1.10%

Bank and Trust

1.05%

Venture Capital

0.34%

機構持股

更新時間: 7月1日週二

報告期間

機構數

持股數

持股佔比

持股變動

2025Q2

634

60.63M

105.91%

-341.50K

2025Q1

643

60.20M

105.40%

-1.30M

2024Q4

610

59.75M

105.65%

+533.86K

2024Q3

567

57.47M

104.31%

-894.95K

2024Q2

545

56.86M

103.79%

-713.22K

2024Q1

509

54.47M

110.12%

-1.91M

2023Q4

480

53.71M

109.34%

-1.79M

2023Q3

475

52.90M

108.58%

-1.85M

2023Q2

486

51.69M

106.83%

-2.99M

2023Q1

490

50.54M

105.57%

-3.20M

股東持股明細

名稱

持股數

佔比

持股變動

變動比例

公告日期

BlackRock Institutional Trust Company, N.A.

7.64M

13.38%

-218.59K

-2.78%

Mar 31, 2025

The Vanguard Group, Inc.

5.95M

10.42%

-9.86K

-0.17%

Mar 31, 2025

Fidelity Management & Research Company LLC

5.57M

9.74%

+417.67K

+8.11%

Mar 31, 2025

Wellington Management Company, LLP

2.29M

4.01%

+131.25K

+6.08%

Mar 31, 2025

State Street Global Advisors (US)

1.98M

3.47%

-79.01K

-3.83%

Mar 31, 2025

Burns (Thomas William)

1.50M

2.62%

-5.16K

-0.34%

May 27, 2025

AllianceBernstein L.P.

1.28M

2.24%

+461.39K

+56.53%

Mar 31, 2025

PRIMECAP Management Company

1.22M

2.13%

+4.15K

+0.34%

Mar 31, 2025

Geode Capital Management, L.L.C.

1.22M

2.13%

+17.85K

+1.49%

Mar 31, 2025

Brown Capital Management, LLC

1.19M

2.09%

-155.27K

-11.52%

Mar 31, 2025

持股ETF

更新時間: 8月2日週六

機構名稱

佔比

Invesco S&P SmallCap Health Care ETF

4.22%

Harbor Health Care ETF

2.42%

SPDR S&P Health Care Equipment ETF

1.9%

Invesco S&P SmallCap Momentum ETF

1.66%

ROBO Global Healthcare Technology & Innovation ETF

1.59%

Vanguard S&P Small-Cap 600 Growth Index Fund

0.86%

SPDR S&P 600 Small Cap Growth ETF

0.86%

iShares S&P Small-Cap 600 Growth ETF

0.81%

iShares U.S. Medical Devices ETF

0.67%

SPDR S&P SmallCap 600 ESG ETF

0.62%

Invesco S&P SmallCap Health Care ETF

佔比4.22%

Harbor Health Care ETF

佔比2.42%

SPDR S&P Health Care Equipment ETF

佔比1.9%

Invesco S&P SmallCap Momentum ETF

佔比1.66%

ROBO Global Healthcare Technology & Innovation ETF

佔比1.59%

Vanguard S&P Small-Cap 600 Growth Index Fund

佔比0.86%

SPDR S&P 600 Small Cap Growth ETF

佔比0.86%

iShares S&P Small-Cap 600 Growth ETF

佔比0.81%

iShares U.S. Medical Devices ETF

佔比0.67%

SPDR S&P SmallCap 600 ESG ETF

佔比0.62%

分紅派息

近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股

公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據

Glaukos Corp

87.470USD

Glaukos Corp

87.470

概覽

公司

財務